Loading people...
Lorna Collings is the Chief Executive Officer of ALSA Ventures, a life science venture capital firm based in London, United Kingdom. She brings over 20 years of institutional investment experience across both the private equity and venture capital asset classes, managing capital allocation strategies for various healthcare enterprises. Prior to assuming her current leadership position, Collings built her financial career through senior investment roles at global asset management firms, including EQT and Hermes GPE. Throughout her two decades in the financial sector, she has developed an expertise in evaluating and funding companies operating within the pharmaceutical, biotechnology, and contract research organization industries. Her professional background combines institutional financial structuring with healthcare market analysis to identify viable therapeutic assets. Collings's current focus centers on directing ALSA Ventures' capital into early-stage European drug development companies.
Lorna Collings is a distinguished Investor at ALSA Ventures, a prominent venture capital firm known for its strategic investments in groundbreaking companies. In her pivotal role, Lorna is responsible for sourcing, evaluating, and executing investment opportunities that align with ALSA Ventures' mission to back visionary founders and disruptive technologies. Her expertise lies in identifying early-stage companies with strong market potential and providing the capital and strategic support needed to scale rapidly.
At ALSA Ventures, Lorna Collings primarily focuses on several key sectors poised for significant growth and innovation. These include cutting-edge technology solutions, encompassing areas such as SaaS, artificial intelligence (AI), and FinTech, where she seeks out platforms that are redefining industry standards. She also has a strong interest in healthcare, particularly BioTech and HealthTech startups that are developing novel therapies, diagnostics, or digital health solutions to improve patient outcomes. Furthermore, Lorna is deeply committed to sustainable solutions, investing in companies that are pioneering advancements in renewable energy, clean technology, and environmental sustainability. Her investment philosophy centers on backing founders who are not only innovative but also possess a clear vision for long-term impact and market leadership.
Lorna's impressive career background underpins her success in the venture capital landscape. She brings a robust foundation in finance and strategic analysis, having previously held roles in private equity and corporate development. This experience honed her skills in rigorous due diligence, financial modeling, and understanding complex market dynamics. Prior to joining ALSA Ventures, Lorna was instrumental in several successful exits at a boutique investment firm, giving her invaluable insights into the full lifecycle of a startup, from seed funding to acquisition or IPO. Her hands-on approach extends beyond capital deployment; she actively mentors portfolio companies, leveraging her extensive network and strategic acumen to help them navigate challenges and capitalize on opportunities.
While specific portfolio companies are often confidential, Lorna Collings has been instrumental in backing several promising ventures that have gone on to achieve significant milestones. Her portfolio includes investments in companies that are redefining their respective industries, from AI-driven analytics platforms to groundbreaking health diagnostics and innovative sustainable energy solutions. Lorna's commitment to fostering innovation and supporting entrepreneurial talent makes her a key figure at ALSA Ventures and a respected voice in the investment community.
Lorna Collings is a dedicated Investor at ALSA Ventures, specializing in early-stage investments across technology, healthcare, and sustainable solutions. She focuses on identifying high-potential startups and providing strategic support to drive their growth.
Lorna Collings primarily invests in early-stage companies within key sectors such as technology (SaaS, AI, FinTech), healthcare (BioTech, HealthTech), and sustainable solutions (renewable energy, clean technology).
Lorna Collings works as an Investor at ALSA Ventures, a prominent venture capital firm.
